This segment focuses on the research, development, manufacturing, and marketing of traditional Chinese medicinal products. The company utilizes traditional Chinese medicine (TCM) principles and formulations, combined with modern pharmaceutical technologies, to develop products for various health conditions. Research and development activities include the identification and extraction of active compounds from natural sources, formulation development, and clinical trials to assess efficacy and safety. Technologies employed include advanced extraction techniques, quality control methods, and modern manufacturing processes to ensure product quality and consistency. Therapeutic areas include insomnia, amnesia, heart palpitations, benign prostatic hyperplasia, cough, asthma, and chronic bronchitis. The patient impact is significant, as these products offer alternative treatment options for patients seeking natural remedies. Market positioning is in the Chinese pharmaceutical market, with a focus on both domestic and international markets. Future opportunities include expanding the product portfolio, entering new therapeutic areas, and increasing market share through strategic partnerships and collaborations. Regulatory and clinical aspects involve obtaining necessary approvals from relevant health authorities, conducting clinical trials, and adhering to Good Manufacturing Practices (GMP).

This segment involves the production and marketing of various pharmaceutical injections, including antibiotics and other therapeutic agents. The company utilizes advanced manufacturing processes and stringent quality control measures to ensure the safety and efficacy of its injectable products. Research and development activities focus on improving existing formulations, developing new injectable drugs, and exploring innovative delivery systems. Technologies used include sterile manufacturing processes, advanced analytical techniques, and quality assurance systems. Therapeutic areas covered include infectious diseases, and other conditions requiring injectable medications. The patient impact is significant, as these products provide critical treatments for various medical conditions. Market positioning is within the broader pharmaceutical market, with a focus on providing high-quality injectable medications. Future opportunities include expanding the product portfolio, entering new therapeutic areas, and increasing market share through strategic partnerships and collaborations. Regulatory and clinical aspects involve obtaining necessary approvals from relevant health authorities, conducting clinical trials, and adhering to Good Manufacturing Practices (GMP).

This segment involves investments and participation in medical services, including the Deqing No.3 People's Hospital. The company's involvement in medical services allows for a more integrated approach to healthcare, potentially improving patient outcomes and providing valuable insights into the needs of the market. Research and development activities may include clinical research and trials conducted within the hospital setting. Technologies and methodologies used include modern medical equipment and diagnostic tools. Therapeutic areas covered are broad, encompassing the full range of medical specialties offered by the hospital. The patient impact is significant, as the company's involvement supports the provision of quality healthcare services. Market positioning is within the local healthcare market, with a focus on providing accessible and high-quality medical care. Future opportunities include expanding the scope of medical services, investing in new technologies, and forming strategic partnerships with other healthcare providers. Regulatory and clinical aspects involve adhering to all relevant healthcare regulations and standards, ensuring patient safety, and maintaining high standards of medical practice.